Fate Therapeutics (FATE) SEC Filings & 10K Form

$3.80
-0.07 (-1.81%)
(As of 04/26/2024 ET)

Recent Fate Therapeutics SEC Filings

DateFilerForm TypeView
04/26/2024
3:16 PM
Fate Therapeutics (Filer)
Form ARS
03/25/2024
8:30 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:15 PM
Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13D/A
03/20/2024
4:30 PM
Fate Therapeutics (Filer)
Form 424B5
03/04/2024
12:29 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
5:06 PM
Boxer Capital, LLC (Filed by)
Fate Therapeutics (Subject)
Form SC 13G
02/09/2024
5:19 PM
Capital World Investors (Filed by)
Fate Therapeutics (Subject)
Form SC 13G/A
01/30/2024
3:01 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
12:44 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Fate Therapeutics (Subject)
Form SC 13G/A
01/22/2024
12:46 PM
Fate Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/10/2024
3:29 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:29 PM
Fate Therapeutics (Issuer)
Wolchko J Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:30 PM
Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:30 PM
Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:35 PM
Fate Therapeutics (Subject)
Valamehr Bahram (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:36 PM
Fate Therapeutics (Subject)
TAHL CINDY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:36 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:39 PM
Fate Therapeutics (Subject)
Wolchko J Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
11:17 AM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/28/2023
8:30 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:53 PM
Fate Therapeutics (Subject)
Form SC 13D/A
12/28/2023
3:53 PM
Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13D/A
12/18/2023
10:40 AM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2023
11:15 PM
Fate Therapeutics (Filer)
Form EFFECT
11/09/2023
10:57 AM
Fate Therapeutics (Subject)
TAHL CINDY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2023
4:10 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
3:44 PM
Fate Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/10/2023
10:16 AM
Fate Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
09/01/2023
4:29 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2023
9:40 AM
Fate Therapeutics (Subject)
Xu Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/06/2023
4:18 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
4:19 PM
Fate Therapeutics (Issuer)
Powl Brian T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
2:16 PM
Fate Therapeutics (Subject)
Powl Brian T. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/05/2023
11:57 AM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2023
10:08 AM
Fate Therapeutics (Subject)
Xu Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2023
6:22 PM
Fate Therapeutics (Issuer)
Lee Michael Stewart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
6:22 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
7:52 AM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2023
8:16 AM
Fate Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:FATE) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners